期刊文献+

从外科角度看胃肠间质瘤治疗理念的变迁 被引量:5

The shift of the treatment strategy of gastrointestinal stromal tumor from the surgical perspective
原文传递
导出
摘要 胃肠间质瘤作为起源于间叶组织的软组织肿瘤,其发展历程有其特殊性,也有特别价值。纵观胃肠间质瘤不同历史阶段的治疗理念,外科手术在疾病治疗决策中的地位和价值,以及给患者带来的治疗获益都在不断改进和提升。腹腔镜和内镜治疗也必将在胃肠间质瘤的治疗中发挥相应的作用。随着对疾病发病机制的不断了解和深入,靶向治疗的精准化和个体化都在精益求精。如何进一步提高胃肠间质瘤特别是高危和耐药患者的整体治疗效果,是目前外科医师面临的困难与挑战。 As tumors originated from mesenchymal tissue,gastrointestinal stromal tumors(GIST)has its own typical history.For the idea of treatment for GIST at different historical periods,the role and value of surgery for the treatment of GIST keep changing.Laparoscopy and endoscopy will have the role they deserved.With the understanding of pathogenesis of GIST,targeted chemotherapy will be more and more accurate and individualized.How to improve the overall therapeutic effect of GIST,especially for the patients with the high risk and drug-resistance,is the dilemma and challenges for the surgeons.
作者 秦新裕 沈坤堂 刘凤林 Qin Xinyu;Shen Kuntang;Liu Fenglin(Department of General Surgery,Zhongshan Hospital,Fudan University,Shanghai 200032,China)
出处 《中华外科杂志》 CAS CSCD 北大核心 2020年第1期5-8,共4页 Chinese Journal of Surgery
关键词 胃肠道间质肿瘤 外科 手术 分子靶向治疗 耐药 Gastrointestinal stromal tumors Surgical procedure operative Molecular targeted therapy Drug-resistance
  • 相关文献

参考文献2

二级参考文献36

  • 1Joensuu H, Roberts PJ, Sarlomo-Rikala M, Andersson LC, Ter- vahartiala P, Tuveson D, Silberrnan S, Capdeville R, Dimitrijevic S, Druker B, Demetri GD. Effect of the tyrosine kinase inhibitor STI571 in a patient with a metastatic gastrointestinal stromal tumor. N Engl J Med 2001; 344:1052-1056.
  • 2van Oosterom AT, Judson I, Verweij J, Stroobants S, Donato di Paola E, Dimitrijevic S, Martens M, Webb A, Sciot R, Van Glab- beke M, Silberman S, Nielsen OS. Safety and efficacy of imatinib (STI571) in metastatic gastrointestinal strornal turnouts: a phase I study. Lancet 2001; 358:1421-1423.
  • 3Demetri GD, von Mehren M, Blanke CD, Van den Abbeele AD, Eisenberg B, Roberts PJ, Heinrich MC, Tuveson DA, Singer S, Janicek M, Fletcher JA, Silverman SG, Silberman SL, Capdeville R, Kiese B, Peng B, Dimitrijevic S, Druker BJ, Corless C, Fletcher CD, Joensuu H. Efficacy and safety of imatinib mesylate in advanced gastrointestinal strornal tumors. N Engl J Med 2002; 347:472-480.
  • 4Verweij J, Casali PG, Zalcberg J, LeCesne A, Reichardt P, Blay JY, Issels R, van Oosterom A, Hogendoom PC, Van Glabbeke M, Bertulli R, Judson I. Progression-free survival in gastrointestinal stromal tumours with high-dose imatinib: randomised trial. Lancet 2004; 364:1127-1134.
  • 5DeMatteo RP, Ballman KV, Antonescu CR, Maki RG, Pisters PWT, Demetri GD, Blackstein ME, Blanke CD, von Mehren M, Brennan MF, Patel S, McCarter MD, Polikoff JA, Tan BR, Owzar K, on behalf of the American College of Surgeons Oncology Group (ACOSOG) Intergroup Adjuvant GIST Study Team. Adjuvant imatinib mesylate after resection of localised, primary gastrointestinal stromal tumour: a randornised, double-blind, placebo-controlled trial. Lancet 2009;373:1097-1104.
  • 6Fletcher CD, Berman JJ, Corless C, Gorstein F, Lasota J, Longley BJ, Miettinen M, O'Leary TJ, Remotti H, Rubin BP, Shrnookler B, Sobin LH, Weiss SW. Diagnosis of gastrointestinal stromal tumors: A consensus approach. Hum Pathol 2002; 33:459-465.
  • 7DeMatteo RP, Lewis JJ, Leung D, Mudan SS, Woodruff JM, Brennan MF. Two hundred gastrointestinal stromal tumors: re- currence patterns and prognostic factors for survival. Ann Surg 2000; 231:51-58.
  • 8Ahmed I, Welch NT, Parsons SL. Gastrointestinal stromal tumours (GIST)-17 years experience from Mid Trent Region (United Kingdom). Eur J Surg Oncol 2008; 34:445-449.
  • 9Nilsson B, Biimming P, Meis-Kindblom JM, Odin A, Dortok A, Gustavsson B, Sablinska K, Kindblom LG. Gastrointestinal stromal tumors: the incidence, prevalence, clinical course, and prognostication in the preimatinib mesylate era-a population- based study in western Sweden. Cancer 2005; 103:821-829.
  • 10Novitsky YW, Kercher KW, Sing RF, Heniford BT. Long-term outcomes of laparoscopic resection of gastric gastrointestinal stromal tumors. Ann Surg 2006; 243: 738-745; discussion 745-747.

共引文献143

同被引文献49

引证文献5

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部